AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 292: F1626-F1635, 2007. First published January 9, 2007; doi:10.1152/ajprenal.00339.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/F1626    most recent
00339.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tögel, F.
Right arrow Articles by Westenfelder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tögel, F.
Right arrow Articles by Westenfelder, C.

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury

Florian Tögel,1,2,3 Kathleen Weiss,1 Ying Yang,1 Zhuma Hu,1 Ping Zhang,1 and Christof Westenfelder1,2,3

1Division of Nephrology, Department of Medicine, University of Utah, 2Section of Nephrology, Veterans Affairs Medical Center, and 3Department of Physiology, University of Utah, Salt Lake City, Utah

Submitted 29 August 2006 ; accepted in final form 2 January 2007

Acute kidney injury (AKI) is a major clinical problem in which a critical vascular, pathophysiological component is recognized. We demonstrated previously that mesenchymal stem cells (MSC), unlike fibroblasts, are significantly renoprotective after ischemia-reperfusion injury and concluded that this renoprotection is mediated primarily by paracrine mechanisms. In this study, we investigated whether MSC possess vasculoprotective activity that may contribute, at least in part, to an improved outcome after ischemia-reperfusion AKI. MSC-conditioned medium contains VEGF, HGF, and IGF-1 and augments aortic endothelial cell (EC) growth and survival, a response not observed with fibroblast-conditioned medium. MSC and EC share vasculotropic gene expression profiles, as both form capillary tubes in vitro on Matrigel alone or in cooperation without fusion. MSC undergo differentiation into an endothelial-like cell phenotype in culture and develop into vascular structures in vivo. Infused MSC were readily detected in the kidney early after reflow but were only rarely engrafted at 1 wk post-AKI. MSC attached in the renal microvascular circulation significantly decreased apoptosis of adjacent cells. Infusion of MSC immediately after reflow in severe ischemia-reperfusion AKI did not improve renal blood flow, renovascular resistance, or outer cortical blood flow. These data demonstrate that the unique vasculotropic, paracrine actions elicited by MSC play a significant renoprotective role after AKI, further demonstrating that cell therapy has promise as a novel intervention in AKI.

endothelial cells; angiogenesis; conditioned media; VEGF; renal blood flow; differentiation; apoptosis


Address for reprint requests and other correspondence: C. Westenfelder, Section of Nephrology (111N), VA Medical Center, 500 Foothill Blvd., Salt Lake City, UT 84148 (e-mail: Christof.Westenfelder{at}hsc.utah.edu)




This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
C Bocelli-Tyndall, L Bracci, S Schaeren, C Feder-Mengus, A Barbero, A Tyndall, and G C Spagnoli
Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15
Ann Rheum Dis, August 1, 2009; 68(8): 1352 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
F. H. Bahlmann and D. Fliser
The plasticity of progenitor cells--why is it of interest to the nephrologists?
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2018 - 2020.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
B. Bi, J. Guo, A. Marlier, S. R. Lin, and L. G. Cantley
Erythropoietin expands a stromal cell population that can mediate renoprotection
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1017 - F1022.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. M. Curtis, S. Chen, B. Chen, A. Agarwal, C. A. Klug, and P. W. Sanders
Contribution of intrarenal cells to cellular repair after acute kidney injury: subcapsular implantation technique
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F310 - F314.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Togel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F315 - F321.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. Schmitt and L. G. Cantley
The impact of aging on kidney repair
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1265 - F1272.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
L. Li, P. Truong, P. Igarashi, and F. Lin
Renal and Bone Marrow Cells Fuse after Renal Ischemic Injury
J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3067 - 3077.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
B. Imberti, M. Morigi, S. Tomasoni, C. Rota, D. Corna, L. Longaretti, D. Rottoli, F. Valsecchi, A. Benigni, J. Wang, et al.
Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2921 - 2928.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.